NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT by and between ENDO PHARMACEUTICALS HOLDINGS INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of February 23, 2009Contingent Cash Consideration Agreement • March 2nd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT (this “Agreement”), dated as of February 23, 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, as Paying Agent (the “Paying Agent”).
OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and between ENDO PHARMACEUTICALS HOLDINGS INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of February 23, 2009Octreotide • March 2nd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this “Agreement”), dated as of February 23, 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, as Paying Agent (the “Paying Agent”).
ENDO PHARMACEUTICALS HOLDINGS INC. STOCK OPTION AGREEMENTStock Option Agreement • March 2nd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This Stock Option Agreement (the “Option Agreement”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and the optionee named below (the “Optionee”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2007 Stock Incentive Plan (the “Plan”).
ENDO PHARMACEUTICALS HOLDINGS INC. ENDOCENTIVE STOCK AWARD AGREEMENT UNDER THE 2007 STOCK INCENTIVE PLANStock Award Agreement • March 2nd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This Endocentive Stock Award Agreement (this “Award Agreement”), is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Endo Pharmaceuticals Holdings Inc. 2007 Stock Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
